FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949650109> ?p ?o ?g. }

• W2949650109 endingPage "2952" @default.
• W2949650109 startingPage "2952" @default.
• W2949650109 abstract "A major limitation of cisplatin in the treatment of human ovarian cancers is the onset of resistance, which is multifactorial, with several mechanisms co-existing in tumor cells. Nevertheless, specific analogs of cisplatin may circumvent this resistance, but how this is accomplished is not well understood. The inherent gene expression profile of resistant cells is a potential source for identifying genes not only contributing to resistance but also involved in circumvention of resistance by analogs, such as DACH-acetato-Pt(IV) (DAP). Therefore, we examined gene expression profiles in sensitive A2780 and its isogenic cisplatin-resistant 2780CP ovarian tumor models. Eppendorf DualChip human cancer microarrays indicated that expression of 55 genes in the resistant model was significantly altered (>1.5-fold), with 19 downregulated and 36 upregulated. As expected, several genes reported to be involved in resistance (e.g., MMP#8217;s, EGF, IL6R and SOD1) were upregulated and genes involved in drug sensitivity (e.g., CAV1, EGR1, IRF1 and SPARC) were downregulated in resistant cells. Paradoxically, genes associated with resistance (e.g., ADAM9, CRADD, E2F5 and AXL) were also downregulated and those involved in drug sensitivity (e.g., CASP2 and TRADD) upregulated. Therefore, resistance in 2780CP cells likely represents a net effect of anti- and pro-apoptotic molecular changes. Conversely, circumvention of resistance in these cells by DAP must involve a net shift toward pro-apoptotic events, but which, if any, of the 55 genes are involved in this shift was next investigated by microarray analysis after cisplatin or DAP treatment, but initially in A2780 cells so that effects of the two drugs could be compared without interference from resistance mechanisms. This analysis in sensitive cells did not show drug-induced changes in expression of 10 selected genes that were most upregulated in resistant cells. Of the ten selected genes most downregulated in resistance, CAV1, p21, HGF and CLK1 were induced by cisplatin, but only p21 and HGF were induced by DAP. Which of these two candidate genes plays a role in circumvention of resistance by DAP was examined in drug-treated 2780CP cells. The low basal expression of HGF was unaffected by either drug, but a differential induction of p21 was observed. Western analysis confirmed that p21 was not induced by cisplatin but was elevated by DAP in resistant cells. Moreover, siRNA knockdown investigation in A2780 cells indicated that p21 is a determinant of tumor cell sensitivity for both cisplatin and DAP. These systematic studies demonstrate that resistant cells harbor expected and counterintuitive changes in expression of both pro-apoptotic and anti-apoptotic genes, but restoration by induction of a critical pro-apoptotic gene may be sufficient to circumvent resistance. (NCI grants CA127263 and CA16672). Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 2952." @default.
• W2949650109 created "2019-06-27" @default.
• W2949650109 creator A5006879181 @default.
• W2949650109 creator A5010672995 @default.
• W2949650109 creator A5017604622 @default.
• W2949650109 creator A5042234906 @default.
• W2949650109 date "2009-05-01" @default.
• W2949650109 modified "2023-09-27" @default.
• W2949650109 title "Abstract #2952: Paradoxical molecular changes in cisplatin-resistant ovarian tumor cells: up-regulation of drug-sensitizing and down-regulation of resistance-inducing genes" @default.
• W2949650109 hasPublicationYear "2009" @default.
• W2949650109 type Work @default.
• W2949650109 sameAs 2949650109 @default.
• W2949650109 citedByCount "0" @default.
• W2949650109 crossrefType "journal-article" @default.
• W2949650109 hasAuthorship W2949650109A5006879181 @default.
• W2949650109 hasAuthorship W2949650109A5010672995 @default.
• W2949650109 hasAuthorship W2949650109A5017604622 @default.
• W2949650109 hasAuthorship W2949650109A5042234906 @default.
• W2949650109 hasConcept C104317684 @default.
• W2949650109 hasConcept C114851261 @default.
• W2949650109 hasConcept C121608353 @default.
• W2949650109 hasConcept C127561419 @default.
• W2949650109 hasConcept C150194340 @default.
• W2949650109 hasConcept C186836561 @default.
• W2949650109 hasConcept C2776694085 @default.
• W2949650109 hasConcept C2778239845 @default.
• W2949650109 hasConcept C2780427987 @default.
• W2949650109 hasConcept C502942594 @default.
• W2949650109 hasConcept C54355233 @default.
• W2949650109 hasConcept C8415881 @default.
• W2949650109 hasConcept C86803240 @default.
• W2949650109 hasConceptScore W2949650109C104317684 @default.
• W2949650109 hasConceptScore W2949650109C114851261 @default.
• W2949650109 hasConceptScore W2949650109C121608353 @default.
• W2949650109 hasConceptScore W2949650109C127561419 @default.
• W2949650109 hasConceptScore W2949650109C150194340 @default.
• W2949650109 hasConceptScore W2949650109C186836561 @default.
• W2949650109 hasConceptScore W2949650109C2776694085 @default.
• W2949650109 hasConceptScore W2949650109C2778239845 @default.
• W2949650109 hasConceptScore W2949650109C2780427987 @default.
• W2949650109 hasConceptScore W2949650109C502942594 @default.
• W2949650109 hasConceptScore W2949650109C54355233 @default.
• W2949650109 hasConceptScore W2949650109C8415881 @default.
• W2949650109 hasConceptScore W2949650109C86803240 @default.
• W2949650109 hasLocation W29496501091 @default.
• W2949650109 hasOpenAccess W2949650109 @default.
• W2949650109 hasPrimaryLocation W29496501091 @default.
• W2949650109 hasRelatedWork W1131939179 @default.
• W2949650109 hasRelatedWork W1485941411 @default.
• W2949650109 hasRelatedWork W1503912124 @default.
• W2949650109 hasRelatedWork W161930446 @default.
• W2949650109 hasRelatedWork W1968910928 @default.
• W2949650109 hasRelatedWork W1981691981 @default.
• W2949650109 hasRelatedWork W2041334038 @default.
• W2949650109 hasRelatedWork W2057433540 @default.
• W2949650109 hasRelatedWork W2062078114 @default.
• W2949650109 hasRelatedWork W2093974096 @default.
• W2949650109 hasRelatedWork W2162118018 @default.
• W2949650109 hasRelatedWork W2169908872 @default.
• W2949650109 hasRelatedWork W2215100157 @default.
• W2949650109 hasRelatedWork W2243523388 @default.
• W2949650109 hasRelatedWork W2274573412 @default.
• W2949650109 hasRelatedWork W2313696506 @default.
• W2949650109 hasRelatedWork W2339283357 @default.
• W2949650109 hasRelatedWork W3045001292 @default.
• W2949650109 hasRelatedWork W3082487286 @default.
• W2949650109 hasRelatedWork W71615215 @default.
• W2949650109 hasVolume "69" @default.
• W2949650109 isParatext "false" @default.
• W2949650109 isRetracted "false" @default.
• W2949650109 magId "2949650109" @default.
• W2949650109 workType "article" @default.